Literature DB >> 26211720

Identification of Heart Failure Events in Medicare Claims: The Atherosclerosis Risk in Communities (ARIC) Study.

Anna M Kucharska-Newton1, Gerardo Heiss2, Hanyu Ni3, Sally C Stearns4, Nicole Puccinelli-Ortega5, Lisa M Wruck6, Lloyd Chambless6.   

Abstract

BACKGROUND: We examined the accuracy of Medicare heart failure (HF) diagnostic codes in the identification of acute decompensated (ADHF and chronic stable (CSHF) HF. METHODS AND
RESULTS: Hospitalizations were identified from medical discharge records for Atherosclerosis Risk in Communities (ARIC) study participants with linked Medicare Provider Analysis and Review (MedPAR) files for the years 2005-2009. The ARIC study classification of ADHF and CSHF, based on adjudicated review of medical records, was considered to be the criterion standard. A total 8,239 ARIC medical records and MedPAR records meeting fee-for-service (FFS) criteria matched on unique participant ID and date of discharge (68.5% match). Agreement between HF diagnostic codes from the 2 data sources found in the matched records for codes in any position (κ > 0.9) was attenuated for primary diagnostic codes (κ < 0.8). Sensitivity of HF diagnostic codes found in Medicare claims in the identification of ADHF and CSHF was low, especially for the primary diagnostic codes.
CONCLUSION: Matching of hospitalizations from Medicare claims with those obtained from abstracted medical records is incomplete, even for hospitalizations meeting FFS criteria. Within matched records, HF diagnostic codes from Medicare show excellent agreement with HF diagnostic codes obtained from medical record abstraction. The Medicare data may, however, overestimate the occurrence of hospitalized ADHF or CSHF.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heart failure; Medicare claims; diagnostic codes; validation

Mesh:

Year:  2015        PMID: 26211720      PMCID: PMC4706484          DOI: 10.1016/j.cardfail.2015.07.013

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  11 in total

Review 1.  A systematic review of validated methods for identifying heart failure using administrative data.

Authors:  Jane S Saczynski; Susan E Andrade; Leslie R Harrold; Jennifer Tjia; Sarah L Cutrona; Katherine S Dodd; Robert J Goldberg; Jerry H Gurwitz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

2.  National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008.

Authors:  Jersey Chen; Sharon-Lise T Normand; Yun Wang; Harlan M Krumholz
Journal:  JAMA       Date:  2011-10-19       Impact factor: 56.272

3.  Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria.

Authors:  Wayne D Rosamond; Patricia P Chang; Chris Baggett; Anna Johnson; Alain G Bertoni; Eyal Shahar; Anita Deswal; Gerardo Heiss; Lloyd E Chambless
Journal:  Circ Heart Fail       Date:  2012-01-23       Impact factor: 8.790

4.  Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions.

Authors:  Thomas S Rector; Steven L Wickstrom; Mona Shah; N Thomas Greeenlee; Paula Rheault; Jeannette Rogowski; Vicki Freedman; John Adams; José J Escarce
Journal:  Health Serv Res       Date:  2004-12       Impact factor: 3.402

5.  An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients.

Authors:  K J Carlson; D C Lee; A H Goroll; M Leahy; R A Johnson
Journal:  J Chronic Dis       Date:  1985

6.  Prevalence and mortality rate of congestive heart failure in the United States.

Authors:  D D Schocken; M I Arrieta; P E Leaverton; E A Ross
Journal:  J Am Coll Cardiol       Date:  1992-08       Impact factor: 24.094

7.  Survival after the onset of congestive heart failure in Framingham Heart Study subjects.

Authors:  K K Ho; K M Anderson; W B Kannel; W Grossman; D Levy
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

8.  Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913.

Authors:  H Eriksson; K Caidahl; B Larsson; L O Ohlson; L Welin; L Wilhelmsen; K Svärdsudd
Journal:  Eur Heart J       Date:  1987-09       Impact factor: 29.983

9.  Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard.

Authors:  L Joseph; T W Gyorkos; L Coupal
Journal:  Am J Epidemiol       Date:  1995-02-01       Impact factor: 4.897

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  35 in total

1.  Late-onset epilepsy and 25-year cognitive change: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Emily L Johnson; Gregory L Krauss; Keenan A Walker; Jason Brandt; Anna Kucharska-Newton; Thomas H Mosley; Sevil Yasar; Rebecca F Gottesman
Journal:  Epilepsia       Date:  2020-07-24       Impact factor: 5.864

2.  Controlling for Frailty in Pharmacoepidemiologic Studies of Older Adults: Validation of an Existing Medicare Claims-based Algorithm.

Authors:  Carmen C Cuthbertson; Anna Kucharska-Newton; Keturah R Faurot; Til Stürmer; Michele Jonsson Funk; Priya Palta; B Gwen Windham; Sydney Thai; Jennifer L Lund
Journal:  Epidemiology       Date:  2018-07       Impact factor: 4.822

3.  No increased risk of cardiovascular events in older adults initiating dipeptidyl peptidase-4 inhibitors vs therapeutic alternatives.

Authors:  Mugdha Gokhale; John B Buse; Michele Jonsson Funk; Jennifer Lund; Virginia Pate; Ross J Simpson; Til Stürmer
Journal:  Diabetes Obes Metab       Date:  2017-03-17       Impact factor: 6.577

4.  Association Between Heart Transplantation and Subsequent Risk of Stroke Among Patients With Heart Failure.

Authors:  Alexander E Merkler; Monica L Chen; Neal S Parikh; Santosh B Murthy; Shadi Yaghi; Parag Goyal; Peter M Okin; Maria G Karas; Babak B Navi; Costantino Iadecola; Hooman Kamel
Journal:  Stroke       Date:  2019-03       Impact factor: 7.914

5.  Supplementation With Vitamin D and Omega-3 Fatty Acids and Incidence of Heart Failure Hospitalization: VITAL-Heart Failure.

Authors:  Luc Djoussé; Nancy R Cook; Eunjung Kim; Vijaykumar Bodar; Joseph Walter; Vadim Bubes; Heike Luttmann-Gibson; Samia Mora; Jacob Joseph; I-Min Lee; Christine M Albert; Julie E Buring; J Michael Gaziano; JoAnn E Manson
Journal:  Circulation       Date:  2019-11-11       Impact factor: 29.690

6.  Operationalizing Frailty in the Atherosclerosis Risk in Communities Study Cohort.

Authors:  Anna M Kucharska-Newton; Priya Palta; Sheila Burgard; Michael E Griswold; Jennifer L Lund; Benjamin D Capistrant; Stephen B Kritchevsky; Karen Bandeen-Roche; B Gwen Windham
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-03-01       Impact factor: 6.053

7.  Contemporary Epidemiology of Heart Failure in Fee-For-Service Medicare Beneficiaries Across Healthcare Settings.

Authors:  Rohan Khera; Ambarish Pandey; Colby R Ayers; Vijay Agusala; Sandi L Pruitt; Ethan A Halm; Mark H Drazner; Sandeep R Das; James A de Lemos; Jarett D Berry
Journal:  Circ Heart Fail       Date:  2017-11       Impact factor: 8.790

8.  Incidence of Heart Failure Observed in Emergency Departments, Ambulatory Clinics, and Hospitals.

Authors:  Ricky Camplain; Anna Kucharska-Newton; Thomas C Keyserling; J Bradley Layton; Laura Loehr; Gerardo Heiss
Journal:  Am J Cardiol       Date:  2018-03-01       Impact factor: 2.778

9.  Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study.

Authors:  Emily L Johnson; Gregory L Krauss; Alexandra K Lee; Andrea L C Schneider; Jennifer L Dearborn; Anna M Kucharska-Newton; Juebin Huang; Alvaro Alonso; Rebecca F Gottesman
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

10.  MicroRNA-381 regulates the occurrence and immune responses of coronary atherosclerosis via cyclooxygenase-2.

Authors:  Kaiyou Song; Lianting Li; Guiling Sun; Yanjin Wei
Journal:  Exp Ther Med       Date:  2018-03-12       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.